LOUVAIN-LA-NEUVE, BELGIUM, 25 June 2015 - IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed three separate binding term sheets, containing significant and immediate down-payments, with Proton Partners International (PPI), to install three of its Proteus®ONE compact proton therapy solutions in private clinics in the United Kingdom.
Each term sheet covers delivery of the Proteus®ONE equipment, including next generation Pencil Beam Scanning (PBS) and Cone Beam CT (CBCT) capabilities, and a ten-year maintenance agreement. The typical end-user price for a Proteus®ONE system with such a maintenance contract is between EUR 35 and 40 million. These three centers will be the eighth, ninth and tenth installations of IBA’s compact single-room proton therapy solution and are expected to treat the first patients in 2017.
The proton therapy center in Newport will treat patients from Wales, the south-west of England and the Midlands, and the center in Newcastle will treat patients from the North of England. The location of the third center will be announced at a later date.
These three projects follow the framework agreement that IBA and Philips signed in September 2014 to advance the diagnosis and treatment of cancer and demonstrate the efficiency of the collaboration between the two organizations.
Olivier Legrain, Chief Executive Officer of IBA, commented: “We are delighted that IBA has been selected by Proton Partners International to build its three proton therapy centers, bringing access to the most advanced radiation therapy technology to cancer patients across the United Kingdom. PPI’s choice of IBA not only strengthens our world leading position in proton therapy, but also demonstrates the preference of IBA as the most experienced proton therapy provider in the market and the fastest from signing to treatment.”
Mike Moran, Chief Executive Officer of Proton Partners International Limited, added: "We are delighted to announce that we will be working with IBA, the world leader in proton therapy technology, who will equip our centres to the highest specifications. We are excited about the opportunity to deliver the first high energy Proton Beam Therapy Centres in the UK and we look forward to working with a range of stakeholders to help support the research effort in the wider use of proton beam therapy for the benefit of the patients from all over UK."
